Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis

Oncogene

Volumn 31, Issue 11, 2012, Pages 1366-1375

  Tho, L M ^a,b   Libertini, S ^a   Rampling, R ^b   Sansom, O ^a,b   Gillespie, D A ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

apoptosis; carcinogenesis; checkpoints; DNA damage; genome stability; senescence

Indexed keywords

CHECKPOINT KINASE 1; DIMETHYLBENZ[A]ANTHRACENE; HISTONE H2AX; PHORBOL 13 ACETATE 12 MYRISTATE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM TUMOR; GENE DELETION; GENE EXPRESSION; HAIR FOLLICLE; HAPLOINSUFFICIENCY; HOMOZYGOSITY; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SKIN TUMOR; STAINING; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA DAMAGE; GENE DELETION; GENOMIC INSTABILITY; MICE; MICE, KNOCKOUT; PAPILLOMA; PROTEIN KINASES; SKIN NEOPLASMS;

EUKARYOTA;

EID: 84858332163     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.326     Document Type: Article

References (26)

1. Abel EL, Angel JM, Kiguchi K, DiGiovanni J. (2009). Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications. Nat Protoc 4: 1350-1362.
2. Ashwell S, Janetka JW, Zabludoff S. (2008). Keeping checkpoint kinases in line: New selective inhibitors in clinical trials. Expert Opin Investig Drugs 17: 1331-1340.
3. Bartek J, Lukas J. (2003). Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429.
4. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
5. Bolderson E, Richard DJ, Zhou BB, Khanna KK. (2009). Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. Clin Cancer Res 15: 6314-6320.
6. Braun KM, Niemann C, Jensen UB, Sundberg JP, Silva-Vargas V, Watt FM. (2003). Manipulation of stem cell proliferation and lineage commitment: Visualisation of label-retaining cells in wholemounts of mouse epidermis. Development 130: 5241-5255.
7. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642.
8. Fishler T, Li YY, Wang RH, Kim HS, Sengupta K, Vassilopoulos A et al. (2010). Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. Oncogene 29: 4007-4017.
9. Greenow KR, Clarke AR, Jones RH. (2009). Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation. Oncogene 28: 1443-1453.
10. Hoeijmakers JH. (2009). DNA damage, aging, and cancer. N Engl J Med 361: 1475-1485.
11. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P et al. (1999). Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27: 4324-4327.
12. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H et al. (2008). Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet 40: 1291-1299.
13. Kangsamaksin T, Park HJ, Trempus CS, Morris RJ. (2007). A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol Carcinog 46: 579-584.
14. Kemp CJ. (2005). Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin Cancer Biol 15: 460-473.
15. Lam MH, Liu Q, Elledge SJ, Rosen JM. (2004). Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6: 45-59.
16. Li L, Clevers H. (2010). Coexistence of quiescent and active adult stem cells in mammals. Science 327: 542-545.
17. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K et al. (2000). Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14: 1448-1459.
18. McLean GW, Komiyama NH, Serrels B, Asano H, Reynolds L, Conti F et al. (2004). Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev 18: 2998-3003.
19. Mulherkar R, Kirtane BM, Ramchandani A, Mansukhani NP, Kannan S, Naresh KN. (2003). Expression of enhancing factor/ phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis. Oncogene 22: 1936-1944.
20. Niida H, Murata K, Shimada M, Ogawa K, Ohta K, Suzuki K et al. (2010). Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J 29: 3558-3570.
21. Snippert HJ, Haegebarth A, Kasper M, Jaks V, van Es JH, Barker N et al. (2010). Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327: 1385-1389.
22. Syljuasen RG, Sorensen CS, Hansen LT, Fugger K, Lundin C, Johansson F et al. (2005). Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 25: 3553-3562.
23. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T et al. (2000). Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev 14: 1439-1447.
24. Toledo LI, Murga M, Gutierrez-Martinez P, Soria R, Fernandez- Capetillo O. (2008). ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev 22: 297-302.
25. Vogelstein B, Kinzler KW. (2004). Cancer genes and the pathways they control. Nat Med 10: 789-799.
26. Zaugg K, Su YW, Reilly PT, Moolani Y, Cheung CC, Hakem R et al. (2007). Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci USA 104: 3805-3810.